ArticleFrontiers in neurology2023

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study.

Lucas Hendrik Overeem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.